The currently held novel IP includes e.g.
The company carries out validation of diagnostic (Dx) markers and therapeutic (Rx) targets: the company tests genetic and biomarker discoveries for replication in samples and data accessed by MAS. The company has large biobanks of clinical data and blood, DNA, RNA, serum, plasma and urine samples and comprehensive clinical data for over 10,000 subjects, covering all common diseases. MAS also carries out clinical trials with obesity, dyslipoproteinemia, hypertension and T2D medicines.
MAS-Metabolic Analytical Services Oy. Kuubankatu 4B 48, 00220 Helsinki, Finland.